In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 183.5 | 191.3 | 224.4 | 176.8 | 145.2 | 186.8 | 216.4 | 195.9 | 357.3 | 183.3 | 208.5 | 337.3 | |
| Other Income | 2.2 | 2.1 | 3.3 | 2.2 | 0.8 | 1.6 | 5.3 | 1.4 | 2.5 | 1.4 | 0.2 | 1.1 | |
| Total Income | 185.7 | 193.4 | 227.6 | 179.0 | 146.0 | 188.3 | 221.7 | 197.3 | 359.8 | 184.7 | 208.7 | 338.3 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 36.9 | 38.1 | 40.9 | 37.5 | 26.3 | 33.6 | 45.2 | 38.8 | 76.6 | 55.2 | 48.4 | 54.7 | |
| + Purchases of Stock-in-Trade | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.1 | 0.0 | |
| + Changes in Inventories | 8.9 | -16.8 | 6.0 | -10.4 | 5.4 | 19.2 | 15.8 | 10.4 | -4.2 | -4.0 | 2.0 | 2.5 | |
| + Employee Benefit Expense | 10.0 | 10.5 | 10.0 | 9.7 | 11.8 | 10.5 | 9.9 | 11.2 | 20.9 | 12.3 | 9.7 | 11.0 | |
| + Finance Costs | 0.8 | 0.6 | 0.1 | 0.7 | 0.7 | 0.8 | 0.5 | 0.6 | 1.2 | 3.5 | 4.8 | 11.6 | |
| + Depreciation & Amortisation | 8.9 | 8.5 | 8.2 | 8.0 | 7.5 | 7.0 | 7.2 | 6.1 | 12.3 | 9.5 | 9.5 | 9.5 | |
| + Other Expenses | 109.8 | 110.3 | 119.3 | 118.4 | 93.6 | 123.6 | 117.8 | 111.7 | 220.7 | 117.4 | 110.4 | 239.9 | |
| Total Expenses | 175.3 | 151.4 | 184.7 | 164.0 | 145.3 | 194.8 | 196.4 | 178.8 | 327.6 | 193.9 | 197.9 | 329.2 | |
| EBITDA | 17.9 | 49.0 | 48.0 | 21.6 | 8.1 | -0.2 | 27.7 | 23.8 | 43.2 | 2.4 | 24.9 | 29.2 | |
| EBIT | 9.0 | 40.6 | 39.7 | 13.6 | 0.6 | -7.2 | 20.5 | 17.7 | 30.9 | -7.0 | 15.4 | 19.7 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 10.5 | 42.0 | 43.0 | 15.0 | 0.7 | -6.5 | 25.2 | 18.5 | 32.2 | -9.2 | 10.8 | 9.1 | |
| Pretax Income | 10.5 | 42.0 | 43.0 | 15.0 | 0.7 | -6.5 | 25.2 | 18.5 | 32.2 | -9.2 | 10.8 | 9.1 | |
| + Current Tax | 3.2 | 11.9 | 12.2 | 4.0 | 0.1 | -1.8 | 9.1 | 4.2 | 8.1 | -2.8 | -1.4 | 2.1 | |
| + Deferred Tax | -0.2 | -1.3 | -1.0 | -0.3 | 0.2 | 0.1 | -2.2 | 0.5 | 0.1 | 0.6 | 4.3 | 0.2 | |
| Tax Expense | 3.1 | 10.6 | 11.2 | 3.8 | 0.3 | -1.6 | 6.9 | 4.7 | 8.2 | -2.2 | 2.9 | 2.3 | |
| Net Income | 7.4 | 31.4 | 31.7 | 11.3 | 0.4 | -4.8 | 18.4 | 13.8 | 24.0 | -7.0 | 7.9 | 6.8 | |
| + Net Income — Continuing Ops | 7.4 | 31.4 | 31.7 | 11.3 | 0.4 | -4.8 | 18.4 | 13.8 | 24.0 | -7.0 | 7.9 | 6.8 | |
| + Other Comprehensive Income | -0.6 | -0.4 | 0.8 | -0.3 | -0.6 | 0.1 | 0.3 | -0.6 | -0.4 | -0.5 | 0.0 | -0.2 | |
| Total Comprehensive Income | 6.8 | 31.0 | 32.6 | 11.0 | -0.2 | -4.8 | 18.6 | 13.2 | 23.6 | -7.5 | 8.0 | 6.6 | |
| Net Income to Common | — | — | 0.0 | 0.0 | — | 0.0 | 0.0 | 13.8 | 0.0 | -7.0 | 7.9 | 6.8 | |
| Per Share | |||||||||||||
| Basic EPS | 0.51 | 2.15 | 2.16 | 0.76 | 0.03 | -0.33 | 1.24 | 0.93 | 1.62 | -0.47 | 0.54 | 0.46 | |
| Diluted EPS | 0.50 | 2.15 | 2.17 | 0.76 | 0.03 | -0.33 | 1.24 | 0.93 | 1.62 | -0.47 | 0.54 | 0.46 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | 0.3 | -0.6 | -0.4 | -0.5 | 0.0 | -0.2 | |
| + Items NOT to be Reclassified to P&L | -0.8 | -0.5 | — | -0.3 | -0.8 | 0.1 | 0.3 | -0.8 | -0.5 | -0.6 | 0.0 | -0.3 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.1 | -0.2 | -0.1 | -0.2 | 0.0 | -0.1 | |
| + Tax on Items NOT to be Reclassified — alt tag | -0.2 | -0.1 | -0.8 | -0.1 | -0.2 | 0.0 | — | — | — | — | — | — | |
| Comprehensive Income — Owners of Parent | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.2 | 0.0 | -0.5 | 0.0 | -0.2 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 0.51 | 2.15 | 2.16 | 0.76 | 0.03 | -0.33 | 1.24 | 0.93 | 1.62 | -0.47 | 0.54 | 0.46 | |
| Diluted EPS — Continuing Operations | 0.50 | 2.15 | 2.17 | 0.76 | 0.03 | -0.33 | 1.24 | 0.93 | 1.62 | -0.47 | 0.54 | 0.46 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 137.7 | 169.9 | 177.3 | 149.7 | 113.5 | 134.0 | 155.5 | 146.7 | 284.9 | 132.1 | 145.0 | 280.1 | |
| Gross Margin % | 75.05 | 88.80 | 79.02 | 84.65 | 78.20 | 71.72 | 71.83 | 74.87 | 79.73 | 72.04 | 69.56 | 83.06 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 10.5 | 42.0 | 43.0 | 15.0 | 0.7 | -6.5 | 25.2 | 18.5 | 32.2 | -9.2 | 10.8 | 9.1 | |
| Net Income Adj (tax-effected) | 7.4 | 31.4 | 31.7 | 11.3 | 0.4 | -4.8 | 18.4 | 13.8 | 24.0 | -7.0 | 7.9 | 6.8 | |
| EPS Adj | 0.51 | 2.15 | 2.16 | 0.76 | 0.03 | -0.33 | 1.24 | 0.93 | 1.62 | -0.47 | 0.54 | 0.46 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 146.8 | 146.8 | 147.4 | 147.4 | 147.4 | 147.8 | 147.8 | 147.9 | 147.9 | 147.9 | 147.9 | 147.9 | |